Table 3 Sexual Function Parameters in Optilume BPH Subjects.

From: Two-year long-term follow-up of treatment with the Optilume BPH catheter system in a randomized controlled trial for benign prostatic hyperplasia (The PINNACLE Study)

Measure

 

Group

Baseline

3 Months

6 Months

12 Months

24 Months

IIEF

Erectile Function

n

97

92

91

87

73

Mean ± SD

15.6 ± 10.3

16.5 ± 10.8

19.3 ± 10.3

18.8 ± 10.7

20.4 ± 10.2

Median

20

16.5

19

16

22

Min, Max

1, 30

1, 30

1, 30

1, 30

1, 30

Q1, Q3

6.0, 26.0

5.0, 28.0

5.0, 29.0

6.0, 29.0

8.5, 29.5

Overall Satisfaction

n

96

92

91

86

72

Mean ± SD

5.6 ± 2.7

6.2 ± 2.8

6.3 ± 2.9

6.3 ± 2.9

6.5 ± 2.9

Median

6

6

6

6

7

Min, Max

2, 10

2, 10

2, 10

2, 10

2, 10

Q1, Q3

3.0, 8.0

4.0, 9.0

4.0, 10.0

4.0, 10.0

4.0, 9.0

Measure

 

Group

Baseline

3 Month

6 Month

12 Month

2 Years

MSHQ

Ejaculatory Functiona

n

98

86

87

87

72

Mean ± SD

7.5 ± 3.9

8.5 ± 4.8

8.3 ± 4.5

8.4 ± 4.6

8.6 ± 4.6

Median

7

9

9

9

9

Min, Max

1, 15

1, 15

1, 15

1, 15

1, 15

Q1, Q3

5.0, 10.0

5.0, 13.0

5.0, 12.0

5.0, 12.0

4.5, 13.0

Ejaculation Botherb

n

98

86

87

87

71

Mean ± SD

2.5 ± 1.7

1.9 ± 1.6

2.1 ± 1.7

2.0 ± 1.7

1.8 ± 1.6

Median

3

2

2

2

2

Min, Max

0, 5

0, 5

0, 5

0, 5

0, 5

Q1, Q3

1.0, 4.0

0.0, 3.0

0.0, 4.0

0.0, 3.0

0.0, 3.0

  1. aHigher score = Less ejaculation dysfunction (Possible Range 1–15).
  2. bHigher score = Greater bother with ejaculation difficulties (Possible Range 0–5).